Leap Therapeutics, Inc. (LPTX)
USD 2.9
(-6.75%)
USD 2.9
(-6.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1.5 Million | 1.5 Million | - | - |
| Cost of Revenue | 427 Thousand | 415 Thousand | - | - | 776 Thousand | 49 Thousand |
| Gross Profit | -427 Thousand | -415 Thousand | 1.5 Million | 1.5 Million | -776 Thousand | -49 Thousand |
| Operating Expenses | 87.04 Million | 54.71 Million | 41.7 Million | 29.8 Million | 33.31 Million | 29.99 Million |
| Selling, General and Administrative Expenses | 13.38 Million | 11.79 Million | 10.76 Million | 9.61 Million | 9.08 Million | 8.92 Million |
| Research and Development Expenses | 73.23 Million | 44.96 Million | 32.16 Million | 20.42 Million | 24.36 Million | 21.07 Million |
| Other Expenses | - | -2.05 Million | -1.22 Million | -231 Thousand | -132 Thousand | 756 Thousand |
| Cost and Expenses | 87.04 Million | 54.71 Million | 41.7 Million | 29.8 Million | 33.31 Million | 29.99 Million |
| Operating Income | -87.04 Million | -56.76 Million | -41.42 Million | -28.53 Million | -33.45 Million | -30.75 Million |
| Interest Expense | - | 54 Thousand | 41 Thousand | 39 Thousand | 23 Thousand | 19 Thousand |
| Income Tax Expense | - | 147 Thousand | -24 Thousand | -2000.00 | -3000.00 | 20 Thousand |
| Earnings before Tax | -81.41 Million | -54.44 Million | -40.61 Million | -27.51 Million | -32.9 Million | -23.11 Million |
| Net Income | -81.41 Million | -54.59 Million | -40.58 Million | -27.51 Million | -32.9 Million | -23.13 Million |
| Earnings Per Share Basic | -3.98 | -4.82 | -4.73 | -4.64 | -14.57 | -16.36 |
| Earnings Per Share Diluted | -3.98 | -4.82 | -4.73 | -4.64 | -14.57 | -16.05 |
| Weighted Average Shares Outstanding | 20.44 Million | 11.32 Million | 8.58 Million | 5.93 Million | 2.25 Million | 1.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 20.44 Million | 11.32 Million | 8.58 Million | 5.93 Million | 2.25 Million | 1.44 Million |
| Gross Margin | - | - | 1.00 | 1.00 | - | - |
| EBIT Margin | - | - | -26.79 | -18.81 | - | - |
| Profit Margin | - | - | -27.06 | -18.34 | - | - |
| EBITDA | -80.98 Million | -53.98 Million | -40.01 Million | -26.8 Million | -32.1 Million | -23.05 Million |
| Earnings Before Tax Margin | - | - | -27.62 | -19.03 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 634 Thousand | - | - | - |
| Cost of Revenue | - | 5000.00 | 110 Thousand | 427 Thousand | 107 Thousand | 106 Thousand |
| Gross Profit | - | -5000.00 | 524 Thousand | -427 Thousand | -107 Thousand | -106 Thousand |
| Operating Expenses | 21.25 Million | 14.82 Million | 14.71 Million | 86.61 Million | 14.83 Million | 14.36 Million |
| Selling, General and Administrative Expenses | 3.36 Million | 3.52 Million | 3.02 Million | - | 3.33 Million | 3.55 Million |
| Research and Development Expenses | 17.88 Million | 11.29 Million | 11.68 Million | - | 11.5 Million | 11.1 Million |
| Other Expenses | -253 Thousand | - | 272 Thousand | - | - | - |
| Cost and Expenses | 21.25 Million | 14.82 Million | 14.82 Million | 87.04 Million | 14.83 Million | 14.36 Million |
| Operating Income | -21.25 Million | -14.82 Million | -14.82 Million | -87.04 Million | -14.83 Million | -14.66 Million |
| Interest Expense | - | - | 863 Thousand | - | - | - |
| Income Tax Expense | -202 Thousand | -5000.00 | 664 Thousand | - | 199 Thousand | -16.08 Thousand |
| Earnings before Tax | -20.12 Million | -13.82 Million | -12.46 Million | -81.41 Million | -13.69 Million | -13.39 Million |
| Net Income | -20.12 Million | -13.82 Million | -12.46 Million | -81.41 Million | -13.69 Million | -13.39 Million |
| Earnings Per Share Basic | -0.51 | -0.51 | -0.46 | - | -0.51 | -0.91 |
| Earnings Per Share Diluted | -0.51 | -0.51 | -0.46 | - | -0.51 | -0.91 |
| Weighted Average Shares Outstanding | 39.12 Million | 27.01 Million | 26.98 Million | 20.44 Million | 26.98 Million | 14.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 39.12 Million | 27.01 Million | 26.98 Million | 20.44 Million | 26.98 Million | 14.71 Million |
| Gross Margin | - | - | 0.83 | - | - | - |
| EBIT Margin | - | - | -23.20 | - | - | - |
| Profit Margin | - | - | -19.66 | - | - | - |
| EBITDA | -21.25 Million | -14.82 Million | -14.71 Million | - | -14.83 Million | -13.1 Million |
| Earnings Before Tax Margin | - | - | -23.38 | - | - | - |
BRI
7133
BLR
PMC
CTTAY
KKES